The US Food and Drug Administration (FDA) has approved onabotulinumtoxinA (Botox, Allergan) to ease upper limb spasticity in children and adolescents aged 2 to 17 years, the company announced. Common ...

Upper limb spasticity is a painful condition caused by extremely tight muscles that can't be controlled. It's often a side effect of stroke, neurological disease or brain injury, but a new type of ...

— Achieved key co-primary endpoint on efficacy, with 500U dose demonstrating statistically significant difference from placebo in the Modified Ashworth Score (MAS) improvement from baseline — ...

The indication for adult upper limb spasticity treatment now includes elbow and forearm muscles, intrinsic hand muscles, and thumb muscles. The Food and Drug Administration (FDA) has expanded the ...

Many stroke patients suffer from spasticity of the arm that cause pain and impaired sensorimotor function. But there are ways of identifying such patients ahead of time so that they can obtain the ...

Botulinum toxin type A was first used for the treatment of spasticity in 1989. A small uncontrolled study of treatment of upper limb spasticity after stroke reported encouraging benefits, including ...

Actavis plc ACT received positive news on the regulatory front with the FDA expanded Botox’s label for the treatment of adults with upper limb spasticity to include two thumb muscles (flexor pollicis ...

Allergan announced that the Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License Applications (sBLAs) for Botox (onabotulinumtoxinA) injection for the ...

Allergan plc AGN announced that the FDA has approved its supplemental biologics license application (sBLA) to expand the label of its blockbuster product Botox for pediatric patients with upper limb ...

Henry Winkler, known for his television role as Arthur "The Fonz" Fonzarelli, made it a happy day for many people in the Triangle Tuesday who suffer from upper limb spasticity. Henry Winkler, known ...

- Revance now expects to report topline results from JUNIPER trial in early 2021 - NEWARK, Calif.--(BUSINESS WIRE)-- Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on ...

- BOTOX® is the First and Only FDA-Approved Neurotoxin Treatment for Both Upper and Lower Limb Spasticity - DUBLIN, Jan. 22, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global ...